共 37 条
[2]
[Anonymous], EXP CLIN ENDOCRINOL
[4]
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy:: Post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2007, 18 (05)
:1540-1546
[5]
Re-examining RAS-blocking treatment regimens for abrogating progression of chronic kidney disease
[J].
NATURE CLINICAL PRACTICE NEPHROLOGY,
2009, 5 (01)
:12-13
[7]
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2010, 303 (05)
:423-429
[8]
Hou J, 2015, CLIN THER S, p[00847, S0149]
[9]
Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2003, 14 (04)
:992-999